Newsletter

Market news

Stakk’s Big Leap: Partnering with Robinhood, But Does the Business Have Staying Power?

When a small-cap stock surges by hundreds of per cent in a single day, it commands attention. That’s exactly what happened with Stakk Ltd (ASX: SKK), formerly Douugh, after announcing a partnership with U.S. trading giant Robinhood Markets. Shares surged more than 300 per cent intraday, with Stockhead reporting a 267 per cent gain in…

ByUjjwal MaheshwariSeptember 25, 2025

Silex’s Nuclear Tech Leap: Ready to Harvest Gains in Uranium Green Shift?

Silex Systems (ASX: SLX) has taken a major step forward in its effort to commercialise its laser-based uranium enrichment technology. Its U.S. partner, Global Laser Enrichment (GLE), has begun large-scale demonstration testing in North Carolina, aiming to advance the SILEX process to Technology Readiness Level 6 (TRL-6), pending independent validation. This marks the transition from…

ByUjjwal MaheshwariSeptember 25, 2025

Rapid Critical Metals Raises A$14M, Eyes Silver + Webbs Project – Is the Pivot Working?

Rapid Critical Metals (ASX: RCM) has secured firm commitments to raise A$14 million through a two-tranche placement to fund the acquisition of the Webbs Consol silver project in New South Wales, marking a strategic shift from pure lithium exploration to a broader focus on critical metals and silver. Backed by respected investors including Eric Sprott,…

ByUjjwal MaheshwariSeptember 25, 2025

Dateline Resources: Can DTR’s Exploration Momentum Break Out?

Dateline Resources (ASX: DTR), a metals and mining exploration company, is quickly capturing attention among investors, particularly within the small-cap sector. Recent developments, including a surge in stock price and heightened interest in commodity tailwinds, have positioned DTR as a company to watch closely. Despite its modest beginnings, DTR's exploration portfolio and exploration potential have…

ByUjjwal MaheshwariSeptember 25, 2025

Cleo Diagnostics: Regulatory Milestones or Long Road Ahead?

Cleo Diagnostics Ltd (ASX:COV) is a name that has gained significant attention in the diagnostics and medical technology sector. While the company has made impressive strides in its field, particularly with its innovative diagnostic solutions, investors are keen to know: Does it have what it takes to succeed in a market teeming with competition and…

ByUjjwal MaheshwariSeptember 24, 2025

RBA Faces Pressure as Inflation Hits Highest Level in a Year

CPI Hits 3%: What Rising Prices Mean for Households, Markets, and the RBA Australia is already one of the most expensive places to live, and inflation is beginning to creep higher again. The latest CPI reading came in at 3%, the hottest in over a year, pushing price growth back to the top of…

ByCharlie YouldenSeptember 24, 2025

Amplitude’s $151m Raising Sparks 11% Share Price Slide as Market Prices in Dilution

Why Amplitude’s $151m Raise Could Reshape Australia’s East Coast Market Amplitude Energy (ASX: AMX) has just pulled off a $151 million capital raise, and the timing could not be more critical. While many resource companies are tightening their belts, Amplitude is doubling down on growth with its East Coast Supply Project, a development plan that…

ByCharlie YouldenSeptember 24, 2025

H-1B Under Pressure: Can Trump’s Fee Protect U.S. Jobs Without Hurting Innovation?

Imagine paying USD 100,000 fee just to bring in quality talent for a job with the H-1B program. That is the reality some of America’s largest technology companies may soon face under a proposal from the Trump administration, which set out to attach a six-figure fee to every new H-1B visa application. The H-1B program…

ByCharlie YouldenSeptember 24, 2025

Market Relief or Market Risk? What Fed Cuts, Rising Debt, means for Investors

Why Fed Cuts and Soaring Debt Could Reshape Portfolios The Federal Reserve’s decision to cut rates by 25 basis points this week comes at a moment when the U.S. labour market looks far weaker than many investors realised. Recent revisions revealed nearly one million fewer jobs than initially reported, a reminder that cracks may be…

ByCharlie YouldenSeptember 18, 2025

Big Bank Bloodletting: ANZ and the Big-4 Job Cuts Signal More than Cost-Cutting

ANZ (ASX: ANZ) has announced one of the most significant restructures in Australian banking in recent years, confirming it will cut about 3,500 full-time jobs alongside 1,000 contractor roles. The programme, costing around A$560 million, is designed to reduce expenses and improve efficiency. While thousands of staff will be affected, the implications extend far beyond…

ByUjjwal MaheshwariSeptember 15, 2025